T. Kirihara

发表

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.

Naveed B K Shams, Noriko Odani-Kawabata, K. Yamamura, 2018, Investigative ophthalmology & visual science.

Glaucoma Pharmacologic Characterization of Omidenepag Isopropyl , a Novel Selective EP 2 Receptor Agonist , as an Ocular Hypotensive Agent

Naveed B K Shams, Noriko Odani-Kawabata, K. Yamamura, 2018 .

Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination

M. Fuwa, K. Kawazu, H. Mano, 2016, PloS one.

Stereocontrolled construction of octahydroquinolizines, octahydroindolizines, hexahydrobenzo[a]quinolizines, and an octahydroindolo[2,3-a]quinolizine by an intramolecular double Michael reaction: synthesis of (±)epilupinine

M. Ihara, T. Kametani, K. Fukumoto, 1987 .

Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl.

Naveed B K Shams, Noriko Odani-Kawabata, R. Iwamura, 2018, Journal of medicinal chemistry.

A novel synthesis of benzo- and indolo[a]quinolizidines by intramolecular diels-alder reaction of l-azadienes

M. Ihara, T. Kametani, K. Fukumoto, 1984 .

Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity.

M. Nakao, H. Hayashi, H. Tanihara, 2016, Investigative ophthalmology & visual science.

Ocular hypotensive efficacy of Src-family tyrosine kinase inhibitors via different cellular actions from Rock inhibitors.

N. Miyawaki, Masatsugu Nakamura, T. Kirihara, 2014, Experimental eye research.

Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum

S. Shibata, T. Moriya, Y. Minami, 1999, British journal of pharmacology.

Effects of the new ethacrynic acid oxime derivative SA12590 on intraocular pressure in cats and monkeys.

D. Epstein, P. Rao, H. Tajima, 2004, Biological & pharmaceutical bulletin.

Omidenepag isopropyl, a selective EP2 agonist, shows additive intraocular pressure (IOP)-lowering effects when used concomitantly with existing anti-glaucoma drugs in animal models

Jin-Zhong Zhang, T. Taniguchi, M. Ichikawa, 2017 .

Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.

M. Fuwa, Naveed B K Shams, Noriko Odani-Kawabata, 2021, Journal of Ocular Pharmacology and Therapeutics.

Construction of indolizidine and quinolizidine ring systems by an intramolecular 1-aza-1,3-diene Diels-Alder reaction. Synthesis of (,9â)-epilupinine

M. Ihara, T. Kametani, K. Fukumoto, 1985 .

Reduced Plasma BDNF Levels in Normal Tension Glaucoma Compared to Open Angle Glaucoma

Satoru Tsuda, Kazuko Omodaka, Yu Yokoyama, 2023, Journal of glaucoma.